ARTICLE | Clinical News
DCP-001 regulatory update
February 6, 2012 8:00 AM UTC
EMA's CHMP issued a positive opinion to grant Orphan Drug designation for DCPrime's DCP-001 to treat acute myelogenous leukemia (AML). The off-the-shelf dendritic cell vaccine based on the company's D...